These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34411006)

  • 41. Safety profile and clinical course of patients with insomnia administered suvorexant by initial treatment status in a post-marketing survey.
    Sano H; Asai Y; Miyazaki M; Iwakura M; Maeda Y; Hara M
    Expert Opin Drug Saf; 2019 Nov; 18(11):1109-1118. PubMed ID: 31478753
    [No Abstract]   [Full Text] [Related]  

  • 42. Antipsychotics for delirium.
    Lonergan E; Britton AM; Luxenberg J; Wyller T
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005594. PubMed ID: 17443602
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Suvorexant for insomnia in patients with psychiatric disorder: A 1-week, open-label study.
    Kishi T; Sakuma K; Okuya M; Ninomiya K; Oya K; Kubo M; Matsui Y; Nomura I; Okuyama Y; Matsunaga S; Iwata N
    Neuropsychopharmacol Rep; 2019 Sep; 39(3):252-255. PubMed ID: 31283862
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel Therapeutic Strategies for Delirium in Patients With Cancer: A Preliminary Study.
    Tanimukai H; Tsujimoto H; Matsuda Y; Tokoro A; Kanemura S; Watanabe M; Tsujio I; Maeda I; Takei K; Nakajima S; Taira T; Tokuyama M; Kai T; Okamoto Y; Goya S; Kashiwagi Y
    Am J Hosp Palliat Care; 2016 Jun; 33(5):456-62. PubMed ID: 25550442
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of combined use of Suvorexant and Ramelteon in preventing postoperative delirium: a retrospective comparative study.
    Ikeuchi S; Tanaka R; Sugiura T; Shinsato K; Wakabayashi A; Sato J; Suzuki K; Shino M
    J Pharm Health Care Sci; 2023 Dec; 9(1):42. PubMed ID: 38037168
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of aripiprazole for delirium in the elderly: a short review.
    Kirino E
    Psychogeriatrics; 2015 Mar; 15(1):75-84. PubMed ID: 25514894
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug therapy for delirium in terminally ill adults.
    Finucane AM; Jones L; Leurent B; Sampson EL; Stone P; Tookman A; Candy B
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004770. PubMed ID: 31960954
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of suvorexant on morphine tolerance and dependence in mice: Role of NMDA, AMPA, ERK and CREB proteins.
    Esmaili-Shahzade-Ali-Akbari P; Hosseinzadeh H; Mehri S
    Neurotoxicology; 2021 May; 84():64-72. PubMed ID: 33609567
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Suvorexant for Primary Insomnia: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.
    Kishi T; Matsunaga S; Iwata N
    PLoS One; 2015; 10(8):e0136910. PubMed ID: 26317363
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Suvorexant in Elderly Patients with Insomnia: Pooled Analyses of Data from Phase III Randomized Controlled Clinical Trials.
    Herring WJ; Connor KM; Snyder E; Snavely DB; Zhang Y; Hutzelmann J; Matzura-Wolfe D; Benca RM; Krystal AD; Walsh JK; Lines C; Roth T; Michelson D
    Am J Geriatr Psychiatry; 2017 Jul; 25(7):791-802. PubMed ID: 28427826
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical profile of suvorexant for the treatment of insomnia over 3 months in women and men: subgroup analysis of pooled phase-3 data.
    Herring WJ; Connor KM; Snyder E; Snavely DB; Zhang Y; Hutzelmann J; Matzura-Wolfe D; Benca RM; Krystal AD; Walsh JK; Lines C; Roth T; Michelson D
    Psychopharmacology (Berl); 2017 Jun; 234(11):1703-1711. PubMed ID: 28265715
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Perospirone in the treatment of patients with delirium.
    Takeuchi T; Furuta K; Hirasawa T; Masaki H; Yukizane T; Atsuta H; Nishikawa T
    Psychiatry Clin Neurosci; 2007 Feb; 61(1):67-70. PubMed ID: 17239041
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of Suvorexant on Nocturnal Delirium in Elderly Patients with Alzheimer's Disease: A Case-series Study.
    Hanazawa T; Kamijo Y
    Clin Psychopharmacol Neurosci; 2019 Nov; 17(4):547-550. PubMed ID: 31671494
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The diagnosis and management of delirium in infancy.
    Turkel SB; Jacobson JR; Tavaré CJ
    J Child Adolesc Psychopharmacol; 2013 Jun; 23(5):352-6. PubMed ID: 23782129
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insight Into Reduction of Wakefulness by Suvorexant in Patients With Insomnia: Analysis of Wake Bouts.
    Svetnik V; Snyder ES; Tao P; Scammell TE; Roth T; Lines C; Herring WJ
    Sleep; 2018 Jan; 41(1):. PubMed ID: 29112763
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A new approach to the treatment of delirium: atypical antipsychotics].
    Onur E; Cimilli C
    Turk Psikiyatri Derg; 2005; 16(3):216-24. PubMed ID: 16180154
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antipsychotic prescribing patterns, and the factors and outcomes associated with their use, among patients requiring prolonged mechanical ventilation in the long-term acute care hospital setting.
    Al-Qadheeb NS; O'Connor HH; White AC; Neidhardt A; Albizati M; Joseph B; Roberts RJ; Ruthazer RR; Devlin JW
    Ann Pharmacother; 2013 Feb; 47(2):181-8. PubMed ID: 23386064
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chronotherapeutic efficacy of suvorexant on sleep quality and metabolic parameters in patients with type 2 diabetes and insomnia.
    Yoshikawa F; Shigiyama F; Ando Y; Miyagi M; Uchino H; Hirose T; Kumashiro N
    Diabetes Res Clin Pract; 2020 Nov; 169():108412. PubMed ID: 32911037
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antipsychotics in the treatment of delirium: a systematic review.
    Seitz DP; Gill SS; van Zyl LT
    J Clin Psychiatry; 2007 Jan; 68(1):11-21. PubMed ID: 17284125
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of Suvorexant and Lemborexant for the Prevention of Delirium in Adult Critically Ill Patients at an Advanced Critical Care Center: A Single-Center, Retrospective, Observational Study.
    Matsuoka A; Tobita S; Sogawa R; Shinada K; Murakawa-Hirachi T; Shimanoe C; Monji A; Mizoguchi Y; Miike T; Sakamoto Y
    J Clin Psychiatry; 2022 Nov; 84(1):. PubMed ID: 36350599
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.